Are you eligible for accreditation?
By committing to safe, high-quality cellular therapy, you're already on your way to FACT accreditation. The next step is to determine your eligibility.
Hematopoietic Transplantation and Cellular Therapy
Clinical Program
Perform at least the following number of transplants for new recipients during the 12 months prior to initial accreditation (application may start earlier) and annually thereafter:
Allogeneic: minimum of 10 new allogeneic patients
For multiple clinical sites, minimum of 3 new allogeneic patients at each site
Autologous only: minimum of 5 new autologous patients at each site
For a combined adult and pediatric program, minimum of 5 new patients for each population
Programs may begin the accreditation application process while actively working to achieve these minimum numbers. A new program may also be eligible for provisional accreditation
If immune effector cells (IECs) are administered (not required), administer IEC products to at least the following number of new recipients during 12 months prior to initial accreditation (application may start earlier) and annually thereafter:
Minimum of 5 new recipients at each site
For a combined adult and pediatric program, minimum of 6 new recipients with at least one in each population
For multiple clinical sites, minimum of 3 recipients at each site
Use products collected and processed in facilities that meet FACT-JACIE Standards
Have a team that includes a Clinical Program Director, a Quality Manager, and at least one other physician trained or experienced in hematopoietic progenitor cell therapy. If treating pediatric patients, includes team trained and board certified/eligible for this population
Hold all licenses, registrations, and accreditations as required by appropriate governmental authority for the activities performed (eg, FDA, Joint Commission, DNV, HFAP, non-US equivalent)
Compare 1-year survival outcome to national or international outcome data. Refer to the Clinical Outcomes Resource Center for additional information
Collect, maintain, and submit data in the Transplant Essential Data Forms of the CIBMTR or the Minimum Essential Data-A forms of the EBMT to a national or international database. Refer to the Data Management Resource Center for additional information
Comply with all current FACT-JACIE HCT Clinical Program Standards
Clinical Program Director Eligibility
Licensed to practice medicine in the program’s jurisdiction
Minimum 2 years as attending physician managing HPC transplant patients
Board certified (or equivalent) in Hematology, Medical Oncology, Immunology, or Pediatric Hematology/Oncology
Completes at least 10 hours of continuing education annually in HPC transplantation or cellular therapy
Oversees the Quality Management Program and reviews its effectiveness each year
Marrow, Apheresis, or Other Tissue Collection
Perform at least the number of collection procedures for each type during the 12 months prior to initial accreditation (application may start earlier) and annually thereafter:
Marrow: 1 collection prior to initial accreditation; maintain an annual average of 1 collection thereafter
Apheresis: 10 collections prior to initial accreditation; maintain an annual average of 10 collections thereafter
Other tissues: 1 collection prior to initial accreditation; maintain an annual average of 1 collection thereafter
Use a processing facility that meets FACT Standards
Hold all required licenses, registrations, or accreditations
Maintain a Director, Medical Director, Quality Manager, and at least one staff member performing collections for at least 12 months before accreditation (application may begin earlier)
Implement ISBT 128 or Eurocode coding and labeling systems
Comply with current FACT-JACIE Collection Facility Standards
Collection Facility Director Eligibility
Holds a relevant science degree and ≥2 years’ management experience
Completes ≥10 hours of continuing education annually in HPC transplantation, cellular therapy, or quality management
Oversees and annually reviews the Quality Management Program
Collection Facility Medical Director Eligibility
Licensed physician with ≥2 years’ postgraduate training and experience in cell collection/transplantation
Performs or supervises required procedures:
Marrow: 10 lifetime and ≥1 per year per accreditation cycle
Apheresis: ≥5 in the prior 12 months and annually thereafter
Other tissues: at least one tissue collection procedure
Completes ≥10 hours of continuing education annually in cellular therapy, transplantation, or quality management
For pediatric donors, ensures all physicians and staff are trained and experienced in pediatric procedures
Processing Facility
Conduct cellular therapy product processing under required licenses or registrations (eg, FDA or equivalent)
Hold all required licenses, registrations, or accreditations
Maintain a Director, Medical Director, Quality Manager, and at least one staff member performing processing for >12 months before accreditation (application may begin earlier)
Implement ISBT 128 or Eurocode coding and labeling systems
Comply with current FACT-JACIE Processing Standards
Processing Facility Director Eligibility
Holds a medical/doctoral degree with ≥2 years’ experience, or an advanced degree with ≥10 years’ relevant experience in cellular therapy management
Performs or supervises ≥5 processing procedures in the prior 12 months and annually thereafter
Completes ≥10 hours of continuing education annually in HPC transplantation, cellular therapy, or quality management
Oversees and reviews the Quality Management Program annually
Processing Facility Medical Director Eligibility
Licensed physician with ≥2 years’ postdoctoral training and experience in cellular therapy product preparation and use
Performs or supervises ≥5 processing procedures in the prior 12 months and annually thereafter
Completes ≥10 hours of continuing education annually in HPC transplantation or cellular therapy
Immune Effector Cell Therapy including the Community Setting
NOTE: Programs performing transplants are accredited under FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration.
Clinical Program
Administer IEC products to at least the following number of new recipients during 12 months prior to initial accreditation (application may start earlier) and annually thereafter:
Minimum of 5 new recipients at each site
For a combined adult and pediatric program, minimum of 6 new recipients with at least one in each population
For multiple clinical sites, minimum of 5 recipients at each site
Programs may begin the accreditation application process while actively working to achieve these minimum numbers. A new program may also be eligible for provisional accreditation
Use products collected and processed in facilities that meet FACT-JACIE Standards
Have a team that includes a Clinical Program Director, a Quality Manager, and at least one other physician trained or experienced in cellular therapy or the applicable therapeutic disease area. If treating pediatric patients, includes team trained and board certified/eligible for this population
Hold all licenses, registrations, and accreditations as required by appropriate governmental authority for the activities performed (eg, FDA, Joint Commission, DNV, HFAP, non-US equivalent)
Comply with all current FACT-JACIE IEC Clinical Program Standards or current FACT Community IEC Clinical Program Standards as applicable
Clinical Program Director Eligibility
Licensed to practice medicine in the program's jurisdiction
Board certified (or equivalent) in Hematology, Medical Oncology, Immunology, Pediatric Hematology/Oncology, or the relevant therapeutic area
Minimum 2 years as attending physician managing patients in the therapeutic area
Complete at least 10 hours of continuing education annually in cellular therapy
Oversees the Quality Management Program and reviews its effectiveness each year
Marrow, Apheresis, or Other Tissue Collection
Perform at least the number of collection procedures for each type during the 12 months prior to initial accreditation (application may start earlier) and annually thereafter:
Marrow: 1 collection prior to initial accreditation; maintain an annual average of 1 collection thereafter
Apheresis: 10 collections prior to initial accreditation; maintain an annual average of 10 collections thereafter
Other tissues: 1 collection prior to initial accreditation; maintain an annual average of 1 collection thereafter
Use a processing facility that meets FACT-JACIE IEC Standards
Hold all required licenses, registrations, or accreditations
Maintain a Director, Medical Director, Quality Manager, and at least one staff member performing collections for at least 12 months before accreditation (application may begin earlier)
Comply with current FACT-JACIE IEC Facility Standards
Collection Facility Director Eligibility
Holds a relevant science degree and ≥2 years management experience
Completes ≥10 hours of continuing education annually in HPC transplantation, cellular therapy, or quality management
Oversees and annually reviews the Quality Management Program
Collection Facility Medical Director Eligibility
Licensed physician with ≥2 years' postgraduate training and experience in cell collection
Performs or supervises required procedures based on expertise:
Marrow: 10 lifetime and ≥1 per year per accreditation cycle
Apheresis: ≥5 in the prior 12 months and annually thereafter
Other tissues: at least one tissue collection procedure
Completes ≥10 hours of continuing education annually in cellular therapy, transplantation, quality management, or cell collection
For pediatric donors, ensures all physicians and staff are trained and experienced in pediatric procedures
For Processing
Conduct cellular therapy product processing under required licenses or registrations (eg, FDA or equivalent)
Maintain a Director, Medical Director, Quality Manager, and at least one staff member performing processing for ≥12 months before accreditation (application may begin earlier)
Complies with current FACT-JACIE Processing Standards
Processing Facility Director Eligibility
Holds a medical/doctoral degree with ≥2 years' experience, or an advanced degree with ≥10 years relevant experience in cellular therapy management
Performs or supervises ≥5 processing procedures in the prior 12 months and annually thereafter
Completes ≥10 hours of continuing education annually in HPC transplantation, cellular therapy, or quality management
Oversees and reviews the Quality Management Program annually
Processing Facility Medical Director Eligibility
Licensed physician with ≥2 years' postdoctoral training and experience in cellular therapy product preparation and use
Performs or supervises ≥5 processing procedures in the prior 12 months and annually thereafter
Completes ≥10 hours of continuing education annually in cellular therapy product processing or the applicable therapeutic disease area
Cord Blood Bank
Maintain at least 500 banked cord blood (CB) units prior to inspection
Actively collect and bank CB units
Hold all required registrations, accreditations, and CB unit licenses from appropriate governmental authorities (eg, FDA, Joint Commission, DNV, HFAP, or non-US equivalent)
Maintain a leadership team including:
Cord Blood Bank (CBB) Director
CBB Medical Director
CB Collection Director
CB Processing Facility Director
Quality Unit Manager (distinct from the directors)
Implement ISBT 128 or Eurocode coding and labeling systems
Comply with all current NetCord-FACT International Standards for cord blood collection, banking, and release for administration
CBB Director Eligibility
Doctoral degree in medicine or related scientific field, or post-baccalaureate degree in a relevant science with ≥5 years’ experience in CB processing activities
Training and ≥2 years’ experience in one or more of the following: immunogenetics of transplantation, basic or clinical immunology, immunohematology, basic or clinical hematology, transfusion medicine, blood or tissue banking, or cryobiology
CBB Medical Director Eligibility
Current medical license
Training in hematopoietic cell transplantation or blood/tissue banking
Language requirement: Organizations operating in a language other than English translate required documents into English prior to on-site inspection (see Document Submission Requirements for Cord Blood Banks).
Provisional Accreditation for New Clinical Programs
Provisional Accreditation is an optional process wherein a Clinical Program demonstrates compliance with all Standards except those related to patient numbers and length of attending physician experience. This option may be beneficial to new cellular therapy programs seeking accreditation in order to access cellular therapy products or facilitate reimbursement until they are able to meet the minimum number of patients required for full accreditation.
Contact FACT with any questions related to this option at 402-920-7001 or fact@factglobal.org.